High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$84K
$84,304
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
KALV
S
KalVista Pharmaceuticals, Inc.
Yea Christopher
• Officer • CHIEF DEVELOPMENT OFFICER
Sell to Cover
2026-02-23
$67,669
|
||||||
| KALV |
KalVista Pharmaceuticals, Inc.
|
Officer • CHIEF DEVELOPMENT OFFICER
Sell to Cover
|
2026-02-23 | $67,669 | S | Form 4 |
|
KALV
S
KalVista Pharmaceuticals, Inc.
Yea Christopher
• Officer • CHIEF DEVELOPMENT OFFICER
Sell to Cover
2026-02-18
$16,635
|
||||||
| KALV |
KalVista Pharmaceuticals, Inc.
|
Officer • CHIEF DEVELOPMENT OFFICER
Sell to Cover
|
2026-02-18 | $16,635 | S | Form 4 |